BCAL Diagnostics Limited (ASX:BDX)
0.0600
0.00 (0.00%)
Nov 17, 2026, 10:58 AM AEDT
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 22.12 million as of November 16, 2026. It is the 38,774th most valuable company in the world and the 1,025th biggest in Australia. Its market cap has decreased by 23.87% in one year.
Market Cap
22.12M
Enterprise Value
27.45M
Revenue
2.35M
Global Rank
Country Rank
#1,025 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 22.12M, a decrease of -57.23%. That is a compound annual growth rate of -14.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 22.12M | -42.76% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 619.90M |
| Healius | 417.54M |
| Monash IVF Group | 292.23M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| Rhythm Biosciences | 23.36M |
| ImExHS | 17.95M |